Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis.

J Clin Med · 2020 · PMC7465266 · PMID 32784580

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

did not reach statistical significanceno p-value reported

Contrary to what was expected, in our NMA, the SMD in FVC at 12 months between cyclophosphamide and the placebo, although showing a positive trend in favor of cyclophosphamide (SMD = 0.08), did not reach statistical significance (95% CI, −0.22 to 0.38).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.